HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robyn J Barst Selected Research

Connective Tissue Diseases (Connective Tissue Disease)

11/2010Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings.
7/2010Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
10/2008Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
12/2007Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.
11/2007Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease.
1/2007Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentan.
5/2006Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.
3/2006Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial.
11/2005Sildenafil citrate therapy for pulmonary arterial hypertension.
11/2005Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robyn J Barst Research Topics

Disease

60Pulmonary Arterial Hypertension
11/2015 - 02/2002
16Connective Tissue Diseases (Connective Tissue Disease)
11/2010 - 03/2002
15Pulmonary Hypertension
11/2015 - 03/2002
14Familial Primary Pulmonary Hypertension
11/2011 - 05/2002
10Congenital Heart Defects (Congenital Heart Defect)
11/2010 - 02/2004
6Pain (Aches)
07/2011 - 03/2002
6Dyspnea (Shortness of Breath)
10/2008 - 03/2002
5Sickle Cell Anemia (Hemoglobin S Disease)
03/2014 - 08/2005
5Vascular Diseases (Vascular Disease)
01/2013 - 06/2002
4Hypertension (High Blood Pressure)
10/2014 - 11/2002
3Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
03/2015 - 09/2011
3Sepsis (Septicemia)
09/2012 - 03/2002
3Disease Progression
11/2010 - 06/2003
3Headache (Headaches)
06/2009 - 11/2005
3Flushing
06/2009 - 11/2005
2Hemolysis
09/2011 - 08/2005
2Nausea
10/2008 - 11/2005
2Dyspepsia (Indigestion)
10/2008 - 11/2005
2Infections
04/2008 - 07/2004
2Body Weight (Weight, Body)
01/2006 - 04/2003
1Chronic Renal Insufficiency
02/2015
1Subdural Hematoma (Subdural Hemorrhage)
03/2013
1alpha-Thalassemia
03/2013
1Respiratory Insufficiency (Respiratory Failure)
04/2012
1Right Ventricular Dysfunction
11/2011
1Renal Insufficiency (Renal Failure)
07/2010
1Pericardial Effusion
07/2010
1Hypoxia (Hypoxemia)
06/2009
1Myalgia
06/2009
1Clinical Deterioration
01/2008
1Heart Failure
10/2007
1Thyroid Diseases (Thyroid Disease)
12/2005
1Diarrhea
11/2005
1Edema (Dropsy)
11/2005
1Constipation
11/2005
1Chest Pain (Chest Pains)
11/2005
1Sleep Initiation and Maintenance Disorders (Insomnia)
11/2005
1Rhinitis
11/2005
1Fatigue
08/2004
1Catheter-Related Infections
07/2004
1Erythema
06/2004

Drug/Important Bio-Agent (IBA)

21Epoprostenol (Prostacyclin)FDA LinkGeneric
02/2015 - 03/2002
11treprostinilFDA Link
09/2013 - 03/2002
11Bosentan (Tracleer)FDA Link
06/2011 - 03/2002
10Sildenafil Citrate (Viagra)FDA Link
05/2014 - 08/2005
10sitaxsentanIBA
10/2008 - 06/2002
7Endothelin A ReceptorIBA
11/2007 - 06/2002
6Pharmaceutical PreparationsIBA
01/2013 - 11/2002
5Imatinib Mesylate (Gleevec)FDA Link
11/2015 - 10/2005
5ProstaglandinsIBA
09/2012 - 06/2004
5Vasodilator Agents (Vasodilators)IBA
07/2010 - 02/2004
5Endothelins (Endothelin)IBA
06/2009 - 02/2004
4Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2012 - 08/2005
4Endothelin Receptor AntagonistsIBA
06/2009 - 03/2002
3Tadalafil (Cialis)FDA Link
08/2012 - 06/2009
3Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
02/2010 - 12/2005
3Endothelin Receptors (Endothelin Receptor)IBA
11/2007 - 03/2002
3Vasoconstrictor AgentsIBA
11/2004 - 05/2002
3beraprostIBA
06/2004 - 06/2003
2Brain Natriuretic Peptide (Natrecor)FDA Link
03/2014 - 07/2010
2Oxygen (Dioxygen)IBA
07/2010 - 06/2009
2Calcium Channels (Calcium Channel)IBA
05/2010 - 08/2004
2Iloprost (Ventavis)FDA Link
01/2008 - 12/2006
2Endothelin B ReceptorIBA
11/2005 - 02/2004
2CollagenIBA
06/2003 - 06/2002
1Protein Kinases (Protein Kinase)IBA
11/2015
1Platelet-Derived Growth FactorIBA
03/2013
1Hydroxyurea (Hydrea)FDA LinkGeneric
03/2013
1Fetal Hemoglobin (Hemoglobin F)IBA
03/2013
17-(N-(3-aminopropyl)amino)heptan-2-oneIBA
09/2012
1Biomarkers (Surrogate Marker)IBA
11/2011
1ErythropoietinFDA Link
09/2011
1NitrogenIBA
09/2011
1Urea (Carbamide)FDA LinkGeneric
09/2011
1Carbon MonoxideIBA
07/2010
1DiureticsIBA
06/2009
1Type 1 Angiotensin ReceptorIBA
04/2009
1antineoplaston A10 (A 10)IBA
01/2009
1Serotonin (5 Hydroxytryptamine)IBA
01/2008
1Peptides (Polypeptides)IBA
10/2007
1Natriuretic PeptidesIBA
10/2007
1ambrisentanFDA Link
01/2007
1Dexfenfluramine (Redux)IBA
09/2006
1FenfluramineIBA
09/2006
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
04/2006
1Clostridium perfringens epsilon-toxinIBA
01/2006
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2006
1Warfarin (Coumadin)FDA LinkGeneric
11/2005
1Endothelin-1 (Endothelin 1)IBA
11/2005
1von Willebrand FactorIBA
10/2005
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
10/2005
1SodiumIBA
10/2004

Therapy/Procedure

33Therapeutics
11/2015 - 03/2002
2Subcutaneous Infusions
08/2004 - 03/2002
2Central Venous Catheters
07/2004 - 03/2002
1Operative Surgical Procedures
06/2010
1Cardiac Catheters
12/2006
1Catheters
07/2004
1Transplantation
06/2003
1Intravenous Infusions
02/2003